Sector Chart Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 06:00:00 23/07/26 am AEST			5-day change	1st Jan Change
1.820 ^CAD	+2.82%		+15.19%	+38.93%

12/05	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
07/05	Cardiol Adds Results "Further Validate" Ongoing Phase III Trial, Which Recently Surpassed 75% Enrollment	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CARDIOL THERAPEUTICS INC.	145M	-	-	-	-	-
LONZA GROUP AG	48.5B
REVOLUTION MEDICINES, INC.	38.97B	-	-	-	-	-
BEONE MEDICINES AG	35.43B
IQVIA HOLDINGS INC.	33.65B
CELLTRION, INC.	26.58B